Ultra-High-Field MR Neuroimaging

REFERENCES

1. 1.↵
   2. Clow H,
   3. Young IR

   . Britain's brains produce first NMR scans. New Scientist 1978;80:588
2. 2.↵
   2. Atlas SW

   . Magnetic Resonance Imaging of the Brain and Spine. Vol. 1. Philadelphia: Lippincott Williams & Wilkins; 2009
3. 3.↵
   2. Kraff O,
   3. Fischer A,
   4. Nagel AM, et al

   . MRI at 7 Tesla and above: demonstrated and potential capabilities. J Magn Reson Imaging 2015;41:13–33

   CrossRefPubMed
4. 4.↵
   2. Duyn JH

   . The future of ultra-high field MRI and fMRI for study of the human brain. Neuroimage 2012;62:1241–48

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Uğurbil K,
   3. Adriany G,
   4. Andersen P, et al

   . Ultrahigh field magnetic resonance imaging and spectroscopy. Magn Reson Imaging 2003;21:1263–81

   CrossRefPubMedWeb of Science
6. 6.↵
   2. Fatterpekar GM,
   3. Naidich TP,
   4. Delman BN, et al

   . Cytoarchitecture of the human cerebral cortex: MR microscopy of excised specimens at 9.4 Tesla. AJNR Am J Neuroradiol 2002;23:1313–21

   Abstract/FREE Full Text
7. 7.↵
   2. Naidich TP,
   3. Duvernoy HM,
   4. Delman BN, et al

   . Vascularization of the Cerebellum and the Brain Stem. Vienna: Springer-Verlag; 2009
8. 8.↵
   2. Duvernoy H,
   3. Cattin F,
   4. Naidich TP, et al

   . The Human Hippocampus: Functional Anatomy, Vascularization and Serial Sections with MRI. 3rd ed. Berlin: Springer-Verlag; 2005
9. 9.↵
   2. Kerchner GA

   . Ultra-high field 7T MRI: a new tool for studying Alzheimer's disease. J Alzheimers Dis 2011;26(suppl 3):91–95

   CrossRefPubMed
10. 10.↵
    2. Kollia K,
    3. Maderwald S,
    4. Putzki N, et al

    . First clinical study on ultra-high-field MR imaging in patients with multiple sclerosis: comparison of 1.5T and 7T. AJNR Am J Neuroradiol 2009;30:699–702

    Abstract/FREE Full Text
11. 11.↵
    2. Thomas BP,
    3. Welch EB,
    4. Niederhauser BD, et al

    . High-resolution 7T MRI of the human hippocampus in vivo. J Magn Reson Imaging 2008;28:1266–72

    CrossRefPubMedWeb of Science
12. 12.↵
    2. Wisse LE,
    3. Gerritsen L,
    4. Zwanenburg JJ, et al

    . Subfields of the hippocampal formation at 7 T MRI: in vivo volumetric assessment. Neuroimage 2012;61:1043–49

    CrossRefPubMed
13. 13.↵
    2. Prudent V,
    3. Kumar A,
    4. Liu S, et al

    . Human hippocampal subfields in young adults at 7.0 T: feasibility of imaging. Radiology 2010;254:900–06

    CrossRefPubMed
14. 14.↵
    2. Haacke EM,
    3. Mittal S,
    4. Wu Z, et al

    . Susceptibility-weighted imaging: technical aspects and clinical applications, part 1. AJNR Am J Neuroradiol 2009;30:19–30

    Abstract/FREE Full Text
15. 15.↵
    2. Sanchez-Panchuelo RM,
    3. Besle J,
    4. Beckett A, et al

    . Within-digit functional parcellation of Brodmann areas of the human primary somatosensory cortex using functional magnetic resonance imaging at 7 Tesla. J Neurosci 2012;32:15815–22

    Abstract/FREE Full Text
16. 16.↵
    2. Duong TQ,
    3. Yacoub E,
    4. Adriany G, et al

    . Microvascular BOLD contribution at 4 and 7 T in the human brain: gradient-echo and spin-echo fMRI with suppression of blood effects. Magn Reson Med 2003;49:1019–27

    CrossRefPubMedWeb of Science
17. 17.↵
    2. Yacoub E,
    3. Duong TQ,
    4. Van De Moortele PF

    . Spin-echo fMRI in humans using high spatial resolutions and high magnetic fields. Magn Reson Med 2003;49:655–64

    CrossRefPubMedWeb of Science
18. 18.↵
    2. Bae KT,
    3. Park SH,
    4. Moon CH, et al

    . Dual-echo arteriovenography imaging with 7T MRI. J Magn Reson Imaging 2010;31:255–61

    CrossRefPubMed
19. 19.↵
    2. Mayer D,
    3. Spielman DM

    . Detection of glutamate in the human brain at 3 T using optimized constant time point resolved spectroscopy. Magn Reson Med 2005;54:439–42

    CrossRefPubMedWeb of Science
20. 20.↵
    2. Polders DL,
    3. Leemans A,
    4. Hendrikse J, et al

    . Signal to noise ratio and uncertainty in diffusion tensor imaging at 1.5, 3.0, and 7.0 Tesla. J Magn Reson Imaging 2011;33:1456–63

    CrossRefPubMed
21. 21.↵
    2. Morelli JN,
    3. Runge VM,
    4. Feiweier T, et al

    . Evaluation of a modified Stejskal-Tanner diffusion encoding scheme, permitting a marked reduction in TE, in diffusion-weighted imaging of stroke patients at 3 T. Invest Radiol 2010;45:29–35

    CrossRefPubMed
22. 22.↵
    2. Heidemann RM,
    3. Porter DA,
    4. Anwander A, et al

    . Diffusion imaging in humans at 7T using readout-segmented EPI and GRAPPA. Magn Reson Med 2010;64:9–14

    CrossRefPubMed
23. 23.↵
    2. Feinberg DA,
    3. Setsompop K

    . Ultra-fast MRI of the human brain with simultaneous multi-slice imaging. J Magn Reson 2013;229:90–100

    CrossRefPubMed
24. 24.↵
    2. Setsompop K,
    3. Cohen-Adad J,
    4. Gagoski BA, et al

    . Improving diffusion MRI using simultaneous multi-slice echo planar imaging. Neuroimage 2012;63:569–80

    CrossRefPubMed
25. 25.↵
    2. Nagel AM,
    3. Bock M,
    4. Hartmann C, et al

    . The potential of relaxation-weighted sodium magnetic resonance imaging as demonstrated on brain tumors. Invest Radiol 2011;46:539–47

    CrossRefPubMed
26. 26.↵
    2. Nagel AM,
    3. Laun FB,
    4. Weber MA, et al

    . Sodium MRI using a density-adapted 3D radial acquisition technique. Magn Reson Med 2009;62:1565–73

    CrossRefPubMed
27. 27.↵
    2. Nagel AM,
    3. Lehmann-Horn F,
    4. Weber MA, et al

    . In vivo 35Cl MR imaging in humans: a feasibility study. Radiology 2014;271:585–95

    CrossRefPubMed
28. 28.↵
    2. Thulborn KR,
    3. Davis D,
    4. Snyder J, et al

    . Sodium MR imaging of acute and subacute stroke for assessment of tissue viability. Neuroimaging Clin N Am 2005;15:639–53, xi–xii

    CrossRefPubMedWeb of Science
29. 29.↵
    2. Boada FE,
    3. LaVerde G,
    4. Jungreis C, et al

    . Loss of cell ion homeostasis and cell viability in the brain: what sodium MRI can tell us. Curr Top Dev Biol 2005;70:77–101

    CrossRefPubMed
30. 30.↵
    2. Qian Y,
    3. Zhao T,
    4. Wiggins GC, et al

    . Sodium imaging of human brain at 7 T with 15-channel array coil. Magn Reson Med 2012;68:1807–14

    CrossRefPubMed
31. 31.↵
    2. Qian Y,
    3. Zhao T,
    4. Zheng H, et al

    . High-resolution sodium imaging of human brain at 7 T. Magn Reson Med 2012;68:227–33

    CrossRefPubMed
32. 32.↵
    2. Qiao H,
    3. Zhang X,
    4. Zhu XH, et al

    . In vivo 31P MRS of human brain at high/ultrahigh fields: a quantitative comparison of NMR detection sensitivity and spectral resolution between 4 T and 7 T. Magn Reson Imaging 2006;24:1281–86

    CrossRefPubMedWeb of Science
33. 33.↵
    2. Moser E,
    3. Stahlberg F,
    4. Ladd ME, et al

    . 7-T MR: from research to clinical applications? NMR Biomed 2012;25:695–716

    CrossRefPubMed
34. 34.↵
    2. Trattnig S,
    3. Zbýň S,
    4. Schmitt B, et al

    . Advanced MR methods at ultra-high field (7 Tesla) for clinical musculoskeletal applications. Eur Radiol 2012;22:2338–46

    CrossRefPubMed
35. 35.↵
    2. Madelin G,
    3. Kline R,
    4. Walvick R, et al

    . A method for estimating intracellular sodium concentration and extracellular volume fraction in brain in vivo using sodium magnetic resonance imaging. Sci Rep 2014;4:4763

    PubMed
36. 36.↵
    2. Kerchner GA,
    3. Hess CP,
    4. Hammond-Rosenbluth KE, et al

    . Hippocampal CA1 apical neuropil atrophy in mild Alzheimer disease visualized with 7-T MRI. Neurology 2010;75:1381–87

    CrossRefPubMed
37. 37.↵
    2. Henry TR,
    3. Chupin M,
    4. Lehéricy S, et al

    . Hippocampal sclerosis in temporal lobe epilepsy: findings at 7 T. Radiology 2011;261:199–209

    CrossRefPubMed
38. 38.↵
    2. Zeineh MM,
    3. Parvizi J,
    4. Balchandani P, et al

    . Ultra-high resolution 7.0T MRI of medial temporal lobe epilepsy. In: Proceedings of the Annual Meeting of the International Society for Magnetic Resonance in Medicine, Honolulu, Hawaii. April 18–24, 2009
39. 39.↵
    2. Grabner G,
    3. Nöbauer I,
    4. Elandt K, et al

    . Longitudinal brain imaging of five malignant glioma patients treated with bevacizumab using susceptibility-weighted magnetic resonance imaging at 7 T. Magn Reson Imaging 2012;30:139–47

    CrossRefPubMedWeb of Science
40. 40.↵
    2. Yuh WT,
    3. Christoforidis GA,
    4. Koch RM, et al

    . Clinical magnetic resonance imaging of brain tumors at ultrahigh field: a state-of-the-art review. Top Magn Reson Imaging 2006;17:53–61

    CrossRefPubMed
41. 41.↵
    2. Eapen M,
    3. Zald DH,
    4. Gatenby JC, et al

    . Using high-resolution MR imaging at 7T to evaluate the anatomy of the midbrain dopaminergic system. AJNR Am J Neuroradiol 2011;32:688–94

    Abstract/FREE Full Text
42. 42.↵
    2. Breyer T,
    3. Wanke I,
    4. Maderwald S, et al

    . Imaging of patients with hippocampal sclerosis at 7 Tesla: initial results. Acad Radiol 20120;17:421–26
43. 43.↵
    2. Madan N,
    3. Grant PE

    . New directions in clinical imaging of cortical dysplasias. Epilepsia 2009;50:9–18
44. 44.↵
    2. Schlamann M,
    3. Maderwald S,
    4. Becker W, et al

    . Cerebral cavernous hemangiomas at 7 Tesla: initial experience. Acad Radiol 2010;17:3–6

    CrossRefPubMed
45. 45.↵
    2. Lupo JM,
    3. Li Y,
    4. Hess CP, et al

    . Advances in ultra-high field MRI for the clinical management of patients with brain tumors. Curr Opin Neurol 2011;24:605–15

    CrossRefPubMed
46. 46.↵
    2. Thulborn KR,
    3. Davis D,
    4. Adams H, et al

    . Quantitative tissue sodium concentration mapping of the growth of focal cerebral tumors with sodium magnetic resonance imaging. Magn Reson Med 1999;41:351–59

    CrossRefPubMedWeb of Science
47. 47.↵
    2. Thulborn KR,
    3. Lu A,
    4. Atkinson IC, et al

    . Quantitative sodium MR imaging and sodium bioscales for the management of brain tumors. Neuroimaging Clin N Am 2009;19:615–24

    CrossRefPubMed
48. 48.↵
    2. Ouwerkerk R,
    3. Bleich KB,
    4. Gillen JS, et al

    . Tissue sodium concentration in human brain tumors as measured with 23Na MR imaging. Radiology 2003;227:529–37

    CrossRefPubMedWeb of Science
49. 49.↵
    2. Deistung A,
    3. Schweser F,
    4. Wiestler B, et al

    . Quantitative susceptibility mapping differentiates between blood depositions and calcifications in patients with glioblastoma. PloS One 2013;8:e57924

    CrossRefPubMed
50. 50.↵
    2. Park MJ,
    3. Kim HS,
    4. Jahng GH, et al

    . Semiquantitative assessment of intratumoral susceptibility signals using non-contrast-enhanced high-field high-resolution susceptibility-weighted imaging in patients with gliomas: comparison with MR perfusion imaging. AJNR Am J Neuroradiol 2009;30:1402–08

    Abstract/FREE Full Text
51. 51.↵
    2. Radbruch A,
    3. Wiestler B,
    4. Kramp L, et al

    . Differentiation of glioblastoma and primary CNS lymphomas using susceptibility weighted imaging. Eur J Radiol 2013;82:552–56

    CrossRefPubMed
52. 52.↵
    2. Tallantyre EC,
    3. Morgan PS,
    4. Dixon JE, et al

    . 3 Tesla and 7 Tesla MRI of multiple sclerosis cortical lesions. J Magn Reson Imaging 2010;32:971–77

    CrossRefPubMed
53. 53.↵
    2. Hammond KE,
    3. Metcalf M,
    4. Carvajal L, et al

    . Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron. Ann Neurol 2008;64:707–13

    CrossRefPubMedWeb of Science
54. 54.↵
    2. Ge Y,
    3. Law M,
    4. Herbert J, et al

    . Prominent perivenular spaces in multiple sclerosis as a sign of perivascular inflammation in primary demyelination. AJNR Am J Neuroradiol 2005;26:2316–19

    Abstract/FREE Full Text
55. 55.↵
    2. Ge Y,
    3. Zohrabian VM,
    4. Grossman RI

    . Seven-Tesla magnetic resonance imaging: new vision of microvascular abnormalities in multiple sclerosis. Arch Neurol 2008;65:812–16

    CrossRefPubMedWeb of Science
56. 56.↵
    2. Quinn MP,
    3. Kremenchutzky M,
    4. Menon RS

    . Venocentric lesions: an MRI marker of MS? Front Neurol 2013;4:98

    PubMed
57. 57.↵
    2. Small SA,
    3. Schobel SA,
    4. Buxton RB, et al

    . A pathophysiological framework of hippocampal dysfunction in ageing and disease. Nat Rev Neurosci 2011;12:585–601

    CrossRefPubMed
58. 58.↵
    2. van Rooden S,
    3. Versluis MJ,
    4. Liem MK, et al

    . Cortical phase changes in Alzheimer's disease at 7T MRI: a novel imaging marker. Alzheimers Dement 2014;10:e19–26

    CrossRefPubMed
59. 59.↵
    2. Drevets WC

    . Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr Opin Neurobiol 2001;11:240–49

    CrossRefPubMedWeb of Science
60. 60.↵
    2. Wang Z,
    3. Neylan TC,
    4. Mueller SG, et al

    . Magnetic resonance imaging of hippocampal subfields in posttraumatic stress disorder. Arch Gen Psychiatry 2010;67:296–303

    CrossRefPubMedWeb of Science
61. 61.↵
    2. Drevets WC

    . Neuroimaging studies of mood disorders. Biol Psychiatry 2000;48:813–29

    CrossRefPubMedWeb of Science
62. 62.↵
    2. Price JL,
    3. Drevets WC

    . Neurocircuitry of mood disorders. Neuropsychopharmacology 2010;35:192–216

    CrossRefPubMedWeb of Science
63. 63.↵
    2. McKinnon MC,
    3. Yucel K,
    4. Nazarov A, et al

    . A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder. J Psychiatry Neurosci 2009;34:41–54

    PubMedWeb of Science
64. 64.↵
    2. Malykhin NV,
    3. Lebel RM,
    4. Coupland NJ, et al

    . In vivo quantification of hippocampal subfields using 4.7 T fast spin echo imaging. Neuroimage 2010;49:1224–30

    CrossRefPubMed
65. 65.↵
    2. Huang Y,
    3. Coupland NJ,
    4. Lebel RM, et al

    . Structural changes in hippocampal subfields in major depressive disorder: a high-field magnetic resonance imaging study. Biol Psychiatry 2013;74:62–68

    CrossRefPubMed
66. 66.↵
    2. Liao Y,
    3. Huang X,
    4. Wu Q, et al

    . Is depression a disconnection syndrome? Meta-analysis of diffusion tensor imaging studies in patients with MDD. J Psychiatry Neurosci 2013;38:49–56

    CrossRefPubMedWeb of Science
67. 67.↵
    2. Miguel-Hidalgo JJ,
    3. Baucom C,
    4. Dilley G, et al

    . Glial fibrillary acidic protein immunoreactivity in the prefrontal cortex distinguishes younger from older adults in major depressive disorder. Biol Psychiatry 2000;48:861–73

    CrossRefPubMedWeb of Science
68. 68.↵
    2. Cotter D,
    3. Mackay D,
    4. Chana G, et al

    . Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cereb Cortex 2002;12:386–94

    Abstract/FREE Full Text
69. 69.↵
    2. Si X,
    3. Miguel-Hidalgo JJ,
    4. O'Dwyer G, et al

    . Age-dependent reductions in the level of glial fibrillary acidic protein in the prefrontal cortex in major depression. Neuropsychopharmacology 2004;29:2088–96

    CrossRefPubMedWeb of Science
70. 70.↵
    2. Vaughan JT,
    3. Garwood M,
    4. Collins CM, et al

    . 7T vs. 4T: RF power, homogeneity, and signal-to-noise comparison in head images. Magn Reson Med 2001;46:24–30

    CrossRefPubMedWeb of Science
71. 71.↵
    2. Cox EF,
    3. Gowland PA

    . Simultaneous quantification of T2 and T′2 using a combined gradient echo-spin echo sequence at ultrahigh field. Magn Reson Med 2010;64:1440–45

    CrossRefPubMed
72. 72.↵
    2. Tannús A,
    3. Garwood M

    . Adiabatic pulses. NMR Biomed 1997;10:423–34

    CrossRefPubMed
73. 73.↵
    2. Garwood M,
    3. DelaBarre L

    . The return of the frequency sweep: designing adiabatic pulses for contemporary NMR. J Magn Reson 2001;153:155–77

    CrossRefPubMedWeb of Science
74. 74.↵
    2. Balchandani P,
    3. Glover G,
    4. Pauly J, et al

    . Improved slice-selective adiabatic excitation. Magn Reson Med 2014;71:75–82

    CrossRefPubMed
75. 75.↵
    2. Balchandani P,
    3. Pauly J,
    4. Spielman D

    . Designing adiabatic radio frequency pulses using the Shinnar-Le Roux algorithm. Magn Reson Med 2010;64:843–51

    CrossRefPubMed
76. 76.↵
    2. Conolly S,
    3. Pauly J,
    4. Nishimura D, et al

    . Two-dimensional selective adiabatic pulses. Magn Reson Med 1992;24:302–13

    CrossRefPubMed
77. 77.↵
    2. Balchandani P,
    3. Pauly J,
    4. Spielman D

    . Interleaved narrow-band PRESS sequence with adiabatic spatial-spectral refocusing pulses for 1H MRSI at 7T. Magn Reson Med 2008;59:973–79

    CrossRefPubMed
78. 78.↵
    2. Balchandani P,
    3. Spielman D

    . Fat suppression for 1H MRSI at 7T using spectrally selective adiabatic inversion recovery. Magn Reson Med 2008;59:980–88

    CrossRefPubMed
79. 79.↵
    2. Balchandani P,
    3. Qiu D

    . Semi-adiabatic Shinnar-Le Roux pulses and their application to diffusion tensor imaging of humans at 7T. Magn Reson Imaging 2014;32:804–12

    CrossRefPubMed
80. 80.↵
    2. Scheenen TW,
    3. Heerschap A,
    4. Klomp DW

    . Towards 1H-MRSI of the human brain at 7T with slice-selective adiabatic refocusing pulses. MAGMA 2008;21:95–101

    CrossRefPubMed
81. 81.↵
    2. van Kalleveen IM,
    3. Koning W,
    4. Boer VO, et al

    . Adiabatic turbo spin echo in human applications at 7 T. Magn Reson Med 2012;68:580–87

    CrossRefPubMed
82. 82.↵
    2. Moore J,
    3. Jankiewicz M,
    4. Zeng H, et al

    . Composite RF pulses for B1+-insensitive volume excitation at 7 Tesla. J Magn Reson 2010;205:50–62

    CrossRefPubMed
83. 83.↵
    2. Boer VO,
    3. Siero JC,
    4. Hoogduin H, et al

    . High-field MRS of the human brain at short TE and TR. NMR Biomed 2011;24:1081–88

    CrossRefPubMed
84. 84.↵
    2. Sacolick LI,
    3. Wiesinger F,
    4. Hancu I, et al

    . B1 mapping by Bloch-Siegert shift. Magn Reson Med 2010;63:1315–22

    CrossRefPubMed
85. 85.↵
    2. Khalighi MM,
    3. Rutt BK,
    4. Kerr AB

    . Adiabatic RF pulse design for Bloch-Siegert B1+ mapping. Magn Reson Med 2013;70:829–35

    CrossRefPubMed
86. 86.↵
    2. Saekho S,
    3. Yip CY,
    4. Noll DC, et al

    . Fast-kz three-dimensional tailored radiofrequency pulse for reduced B1 inhomogeneity. Magn Reson Med 2006;55:719–24

    CrossRefPubMed
87. 87.↵
    2. Cloos MA,
    3. Boulant N,
    4. Luong M, et al

    . kT-points: short three-dimensional tailored RF pulses for flip-angle homogenization over an extended volume. Magn Reson Med 2012;67:72–80

    CrossRefPubMed
88. 88.↵
    2. Saranathan M,
    3. Tourdias T,
    4. Kerr AB, et al

    . Optimization of magnetization-prepared 3-dimensional fluid attenuated inversion recovery imaging for lesion detection at 7 T. Invest Radiol 2014;49:290–98

    CrossRefPubMed
89. 89.↵
    2. Zhu Y

    . Parallel excitation with an array of transmit coils. Magn Reson Med 2004;51:775–84

    CrossRefPubMed
90. 90.↵
    2. Grissom W,
    3. Yip CY,
    4. Zhang Z, et al

    . Spatial domain method for the design of RF pulses in multicoil parallel excitation. Magn Reson Med 2006;56;620–69

    CrossRefPubMed
91. 91.↵
    2. Katscher U,
    3. Börnert P,
    4. Leussler C, et al

    . Transmit SENSE. Magn Reson Med 2003;49:144–50

    CrossRefPubMed
92. 92.↵
    2. Wang L,
    3. Wu Y,
    4. Chang G, et al

    . Rapid isotropic 3D-sodium MRI of the knee joint in vivo at 7T. J Magn Reson Imaging 2009;30:606–14

    CrossRefPubMed
93. 93.↵
    2. Staroswiecki E,
    3. Bangerter NK,
    4. Gurney PT, et al

    . In vivo sodium imaging of human patellar cartilage with a 3D cones sequence at 3 T and 7 T. J Magn Reson Imaging 2010;32:446–51

    CrossRefPubMed
94. 94.↵
    2. Chakeres DW,
    3. Kangarlu A,
    4. Boudoulas H, et al

    . Effect of static magnetic field exposure of up to 8 Tesla on sequential human vital sign measurements. J Magn Reson Imaging 2003;18:346–52

    CrossRefPubMed
95. 95.↵
    1. Robitaille P-M,
    2. Berliner LJ

    2. Robitaille P-M

    . Ultra high field magnetic resonance imaging: a historical perspective. In: Robitaille P-M, Berliner LJ, eds. Ultra High Field Magnetic Resonance Imaging. New York: Springer; 2006;26:1–17

    CrossRef
96. 96.↵
    2. Shellock FG

    . MRISAFETY.com. . www.mrisafety.com. Accessed September 20, 2014.
97. 97.
    2. Peters AM,
    3. Brookes MJ,
    4. Hoogenraad FG, et al

    . T2* measurements in human brain at 1.5, 3 and 7 T. Magn Reson Imaging 2007;25:748–53

    CrossRefPubMed
98. 98.
    2. Uludağ K,
    3. Müller-Bierl B,
    4. Uğurbil K

    . An integrative model for neuronal activity-induced signal changes for gradient and spin echo functional imaging. Neuroimage 2009;48:150–65

    CrossRefPubMedWeb of Science
99. 99.
    2. Solomon I

    . Relaxation processes in a system of two spins. Phys Rev 1955;99:559

    CrossRefWeb of Science
100. 100.
     2. Bartha R,
     3. Michaeli S,
     4. Merkle H, et al

     . In vivo 1H2O T2+ measurement in the human occipital lobe at 4T and 7T by Carr-Purcell MRI: detection of microscopic susceptibility contrast. Magn Reson Med 2002;47:742–50

     CrossRefPubMed
101. 101.
     2. Michaeli S,
     3. Garwood M,
     4. Zhu XH, et al

     . Proton T2 relaxation study of water, N-acetylaspartate, and creatine in human brain using Hahn and Carr-Purcell spin echoes at 4T and 7T. Magn Reson Med 2002;47:629–33

     CrossRefPubMed
102. 102.↵
     2. Van Leemput K,
     3. Bakkour A,
     4. Benner T, et al

     . Automated segmentation of hippocampal subfields from ultra-high resolution in vivo MRI. Hippocampus 2009;19:549–57

     CrossRefPubMedWeb of Science
103. 103.↵
     2. Gu M,
     3. Zahr NM,
     4. Spielman DM, et al

     . Quantification of glutamate and glutamine using constant-time point-resolved spectroscopy at 3 T. NMR Biomed 2013;26:164–72

     CrossRefPubMed